These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1631264)

  • 1. The morbidity of multiple sclerosis.
    Swingler RJ; Compston DA
    Q J Med; 1992 Apr; 83(300):325-37. PubMed ID: 1631264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study.
    Pittock SJ; McClelland RL; Mayr WT; Jorgensen NW; Weinshenker BG; Noseworthy J; Rodriguez M
    Ann Neurol; 2004 Aug; 56(2):303-6. PubMed ID: 15293286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of tremor in multiple sclerosis and associated disability in the Olmsted County population.
    Pittock SJ; McClelland RL; Mayr WT; Rodriguez M; Matsumoto JY
    Mov Disord; 2004 Dec; 19(12):1482-5. PubMed ID: 15390075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors for early severity in a childhood multiple sclerosis cohort.
    Mikaeloff Y; Caridade G; Assi S; Suissa S; Tardieu M
    Pediatrics; 2006 Sep; 118(3):1133-9. PubMed ID: 16951008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of multiple sclerosis in Lebanon.
    Yamout B; Barada W; Tohme RA; Mehio-Sibai A; Khalifeh R; El-Hajj T
    J Neurol Sci; 2008 Jul; 270(1-2):88-93. PubMed ID: 18367208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceptions of illness and its development in patients with multiple sclerosis: a prospective cohort study.
    Lerdal A; Celius EG; Moum T
    J Adv Nurs; 2009 Jan; 65(1):184-92. PubMed ID: 19032506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis: relapses and timing of remissions.
    Iuliano G; Napoletano R; Esposito A
    Eur Neurol; 2008; 59(1-2):44-8. PubMed ID: 17917457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.
    Roxburgh RH; Seaman SR; Masterman T; Hensiek AE; Sawcer SJ; Vukusic S; Achiti I; Confavreux C; Coustans M; le Page E; Edan G; McDonnell GV; Hawkins S; Trojano M; Liguori M; Cocco E; Marrosu MG; Tesser F; Leone MA; Weber A; Zipp F; Miterski B; Epplen JT; Oturai A; Sørensen PS; Celius EG; Lara NT; Montalban X; Villoslada P; Silva AM; Marta M; Leite I; Dubois B; Rubio J; Butzkueven H; Kilpatrick T; Mycko MP; Selmaj KW; Rio ME; Sá M; Salemi G; Savettieri G; Hillert J; Compston DA
    Neurology; 2005 Apr; 64(7):1144-51. PubMed ID: 15824338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs and quality of life of multiple sclerosis in Spain.
    Kobelt G; Berg J; Lindgren P; Izquierdo G; Sánchez-Soliño O; Pérez-Miranda J; Casado MA;
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S65-74. PubMed ID: 17310340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progression of functional disability in 70 patients with multiple sclerosis].
    Izquierdo G; Quesada MA; Navarro G; Aguilar J; Rodríguez Moreno E; Girón JM; Martínez-Parra C
    Neurologia; 1991 May; 6(5):170-4. PubMed ID: 1831370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of fatigue in multiple sclerosis: study of a population-based series in Valladolid].
    Tola MA; Yugueros MI; Fernández-Buey N; Fernández-Herranz R
    Rev Neurol; 1998 Jun; 26(154):930-3. PubMed ID: 9658463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Factors associated with the degree of disability among patients of the Spanish Multiple Sclerosis Association of the Community of Madrid].
    Criado-Alvarez JJ; Munugarren R; Romo-Barrientos C
    Rev Neurol; 1997 Oct; 25(146):1539-44. PubMed ID: 9462975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The frequency of multiple sclerosis in Italy: a descriptive study in Ferrara.
    Granieri E; Tola R; Paolino E; Rosati G; Carreras M; Monetti VC
    Ann Neurol; 1985 Jan; 17(1):80-4. PubMed ID: 3985590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADC measurements in various patterns of multiple sclerosis lesions.
    Phuttharak W; Galassi W; Laopaiboon V; Laopaiboon M; Hesselink JR
    J Med Assoc Thai; 2006 Feb; 89(2):196-204. PubMed ID: 16579006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E; Lee JC; Nakamura K; Rudick RA
    Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs and quality of life of multiple sclerosis in Switzerland.
    Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is late-onset multiple sclerosis associated with a worse outcome?
    Tremlett H; Devonshire V
    Neurology; 2006 Sep; 67(6):954-9. PubMed ID: 17000960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age at disability milestones in multiple sclerosis.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):595-605. PubMed ID: 16415309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary progressive forms of multiple sclerosis: application of the new diagnostic criteria in French].
    De Seze J; Mackowiak A; Stojkovic T; Ferriby D; Hautecoeur P; Vermersch P
    Rev Neurol (Paris); 2002 Mar; 158(3):341-5. PubMed ID: 11976594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.